Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Kondo T, Kanai M, Matsubara J, Yamaguchi D, Ura T, Kou T, Itani T, Nomura M, Funakoshi T, Yokoyama A, Doi K, Tamaoki M, Yoshimura M, Uza N, Yamada T, Masui T, Minamiguchi S, Matsumoto S, Ishikawa H, Muto M. Kondo T, et al. Among authors: ishikawa h. Med Oncol. 2023 Apr 11;40(5):144. doi: 10.1007/s12032-023-02011-y. Med Oncol. 2023. PMID: 37039943
Metachronous primary gastric cancer after endoscopic resection in patients with esophageal squamous cell carcinoma.
Hirao M, Katada C, Yokoyama T, Yano T, Suzuki H, Furue Y, Yamamoto K, Doyama H, Koike T, Tamaoki M, Kawata N, Kawahara Y, Katagiri A, Ogata T, Yamanouchi T, Kiyokawa H, Kawakubo H, Konno M, Ishikawa H, Yokoyama A, Muto M. Hirao M, et al. Among authors: ishikawa h. Gastric Cancer. 2023 Nov;26(6):988-1001. doi: 10.1007/s10120-023-01413-1. Epub 2023 Jun 27. Gastric Cancer. 2023. PMID: 37368170
Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.
Katada C, Yokoyama T, Mure K, Doyama H, Nakanishi H, Shimizu Y, Yamamoto K, Furue Y, Tamaoki M, Koike T, Kawahara Y, Kiyokawa H, Konno M, Yokoyama A, Ohashi S, Ishikawa H, Yokoyama A, Muto M. Katada C, et al. Among authors: ishikawa h. Jpn J Clin Oncol. 2023 Aug 30;53(9):774-780. doi: 10.1093/jjco/hyad070. Jpn J Clin Oncol. 2023. PMID: 37370215
Alcohol consumption, multiple Lugol-voiding lesions, and field cancerization.
Katada C, Yokoyama T, Yano T, Suzuki H, Furue Y, Yamamoto K, Doyama H, Koike T, Tamaoki M, Kawata N, Hirao M, Kawahara Y, Ogata T, Katagiri A, Yamanouchi T, Kiyokawa H, Kawakubo H, Konno M, Yokoyama A, Ohashi S, Kondo Y, Kishimoto Y, Kano K, Mure K, Hayashi R, Ishikawa H, Yokoyama A, Muto M. Katada C, et al. Among authors: ishikawa h. DEN Open. 2023 Jul 3;4(1):e261. doi: 10.1002/deo2.261. eCollection 2024 Apr. DEN Open. 2023. PMID: 37409321 Free PMC article. Review.
Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection.
Hori K, Katada C, Okada H, Katagiri A, Matsuo Y, Yokoyama T, Yano T, Suzuki H, Shimizu Y, Furue Y, Nakanishi H, Koike T, Takizawa K, Hirao M, Yoshii T, Yamanouchi T, Kawakubo H, Kobayashi N, Shimoda T, Ochiai A, Ishikawa H, Yokoyama A, Muto M. Hori K, et al. Among authors: ishikawa h. Esophagus. 2024 Jan;21(1):31-40. doi: 10.1007/s10388-023-01033-9. Epub 2023 Dec 9. Esophagus. 2024. PMID: 38070099
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial.
Katada C, Yokoyama T, Watanabe A, Hara H, Yoshii T, Fujii H, Yamaguchi H, Nakajima TE, Izawa N, Ando T, Nomura M, Kojima T, Yamashita K, Kawakami S, Ishiyama H, Inoue Y, Sakamoto Y, Sasaki H, Ishikawa H, Hosokawa A, Hamamoto Y, Muto M, Tahara M, Koizumi W. Katada C, et al. Among authors: ishikawa h. Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1353-1362. doi: 10.1016/j.ijrobp.2024.06.019. Epub 2024 Jul 3. Int J Radiat Oncol Biol Phys. 2024. PMID: 38969179 Clinical Trial.
Field Effect of Alcohol, Cigarette Smoking, and Their Cessation on the Development of Multiple Dysplastic Lesions and Squamous Cell Carcinoma: A Long-term Multicenter Cohort Study.
Muto M, Katada C, Yokoyama T, Yano T, Oda I, Ezoe Y, Tanabe S, Shimizu Y, Doyama H, Koike T, Takizawa K, Hirao M, Okada H, Ogata T, Katagiri A, Yamanouchi T, Matsuo Y, Kawakubo H, Omori T, Kobayashi N, Shimoda T, Ochiai A, Ishikawa H, Baba K, Amanuna Y, Yokoyama A, Ohashi S, Yokoyama A; Japan Esophageal Cohort Study Group. Muto M, et al. Among authors: ishikawa h. Gastro Hep Adv. 2022 Mar 15;1(2):265-276. doi: 10.1016/j.gastha.2021.10.005. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131127 Free PMC article.
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial.
Nomura M, Yamaguchi T, Chin K, Hato S, Kato K, Baba E, Matsubara H, Mukaida H, Yoshii T, Tsuda M, Tsubosa Y, Kitagawa Y, Oze I, Ishikawa H, Muto M. Nomura M, et al. Among authors: ishikawa h. Ann Surg Oncol. 2024 Oct 7. doi: 10.1245/s10434-024-16325-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39375260
Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study.
Takeuchi Y, Hamada K, Nakahira H, Shimamoto Y, Sakurai H, Tani Y, Shichijo S, Maekawa A, Kanesaka T, Yamamoto S, Higashino K, Fujisawa F, Ezoe Y, Ishikawa H, Mutoh M, Uedo N, Nojima M, Ishihara R. Takeuchi Y, et al. Among authors: ishikawa h. Endoscopy. 2023 Jun;55(6):515-523. doi: 10.1055/a-1983-5963. Epub 2022 Nov 21. Endoscopy. 2023. PMID: 36410678 Clinical Trial.
4,527 results